In this study, we examined whether the proportion of tubal factor infertility (TFI) that is attributable to Chlamydia trachomatis, the population excess fraction (PEF), can be estimated from serological data using finite mixture modeling. Whole-cell inclusion immunofluorescence serum antibody titers were recorded among infertile women seen at St. Michael's Hospital in Bristol, United Kingdom, during the period 1985-1995. Women were classified as TFI cases or controls based on laparoscopic examination. Finite mixture models were used to identify the number of component titer distributions and the proportion of serum samples in each, from which estimates of PEF were derived. Four titer distributions were identified. The component at the highest titer was found only in samples from women with TFI, but there was also an excess of the second-highest titer component in TFI cases. Minimum and maximum estimates of the PEF were 28.0% (95% credible interval: 6.9, 50.0) and 46.8% (95% credible interval: 23.2, 64.1). Equivalent estimates based on the standard PEF formula from case-control studies were 0% and over 65%. Finite mixture modeling can be applied to serological data to obtain estimates of the proportion of reproductive damage attributable to C. trachomatis. Further studies using modern assays in contemporary, representative populations should be undertaken.
Chlamydia trachomatis (CT) is a common sexually transmitted infection of young people which if left untreated will cause pelvic inflammatory disease (PID) in approximately 16% of women (1) . PID may then result in adverse reproductive outcomes, such as ectopic pregnancy or tubal factor infertility (TFI) (2) . In spite of research using a wide range of study designs, the precise quantitative relationship between CT and reproductive damage remains elusive (2) (3) (4) . CT infection, with or without the development of disease, usually resolves spontaneously. Diagnosed infection is treated, so prospective study of untreated infection is not feasible. The major studies of reproductive outcomes in women with PID (5-7) have been restricted to the small proportion of PID cases that are diagnosed in a hospital (8) . In the 1980s and 1990s, large numbers of serological case-control studies were carried out, comparing serum antibody levels in women with PID, ectopic pregnancy, or infertility with those in controls (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . These studies invariably showed strong associations between detection of CT antibodies and reproductive damage, but it was difficult to draw quantitative conclusions from them, partly because of confounding between CT and other pathogens also implicated in reproductive morbidity (20) and partly because of the poor and imprecisely known sensitivity and specificity of the assays used (21, 22) .
In this paper, we adopt a new analytical approach to this problem: finite mixture modeling (23) . Finite mixture models are used when a distribution-in this case, the distribution of serum antibody titers-is considered to be a mixture of several components (e.g., "positives" and "negatives") and where there is an interest in estimating the proportion of serum samples in diseased and healthy populations for each component. Finite mixture models are often applied to diagnostic tests which lack a "gold standard," including to serological data (24) (25) (26) (27) (28) .
In this paper, we apply finite mixture models to a previously published data set (29) . Whole-cell inclusion immunofluorescence (WIF) serum antibody titers were recorded in infertile women classified as either having (cases) or not having (controls) TFI following laparoscopy (Table 1) . Among the cases, a high proportion of the titers that would normally be considered positive (1:32 and above) were at particularly high levels. This has been observed repeatedly in similar studies of TFI (11, 15, 16, 30, 31) and PID (10, 18) . In other words, women at higher risk of reproductive damage are more likely to be CT-antibody-positive and are more likely to have particularly high titers than antibodypositive controls.
Studies carried out in Lund, Sweden, in the 1980s and 1990s (5-7) established that clinically diagnosed PID was associated with reproductive damage only in women with laparoscopically confirmed salpingitis. Our analysis, therefore, was premised on the assumption that the exceptionally high positive titers seen in TFI cases reflect an inflammatory reaction to CT that is associated with CT-related salpingitis, and that women with titers at these high levels are at risk of CTrelated TFI (32) . The purpose of our finite mixture analysis was to determine what proportion of the TFI cases had titers at these high levels.
The estimates of the population excess fraction (PEF) formed in this way will be of substantive interest in the many countries where Chlamydia prevention and control strategies are in operation or are being considered. However, in view of the limitations inherent in using data collected many years ago for another purpose, this paper should be seen in part as an exploratory, hypothesis-forming exercise into how and whether finite mixture modeling of anti-CT titers can contribute to an understanding of the role of CT in reproductive damage.
METHODS

Data
The primary data set consisted of WIF titers from 434 case women with TFI confirmed upon laparoscopy and 573 controls who were infertile for other reasons, seen in a reproductive medicine clinic at St. Michael's Hospital in Bristol, United Kingdom, between 1985 and 1995. The data were collected in a study exploring the relationship between serum Chlamydia antibody titers and detection of tubal damage in infertile women, as previously reported (29) ( Table 1) . Titers of 1:32 or greater would normally be considered positive for CT antibody. Cases had a mean age of 29.3 years (range, and controls a mean age of 30.6 years (range, .
A proportion of low WIF-positive titers are likely to represent cross-reactions to Chlamydia pneumoniae in women with no exposure to CT (33) . A secondary data set provided additional information on the proportion of women at each WIF titer who had never been infected with CT. Anonymized serum samples from women undergoing investigation for infertility in 2013 were submitted to Public Health Laboratory Bristol and tested via WIF at Public Health Laboratory Bristol and via the highly specific Pgp3 CT antibody assay (33) at Imperial College London. The analyses described here concerned samples collected from 301 women with WIF titers at or below 
Models
We examined 3 models, each characterized by the number of latent distributions of WIF antibody titers assumed to be present (Table 2 ). For example, the "2-3" model assumed that the control samples were a mixture of 2 distributions, which we label CT− (never infected with CT) and CT+ (previously infected but no inflammatory response), while TFI samples may have come from either of these distributions or from a third distribution, CT++, representing women who have had an inflammatory response to CT infection.
We developed further models when we found that the "2-3" model did not fit the data. In the "3-3" model, a proportion of control samples is also allowed to belong to the CT++ distribution. In the "3-4" model, a further distribution is proposed, CT+++, but only TFI samples may belong to it. These labels should be thought of simply as mnemonics, although, as the labels suggest, they are listed in order of increasing titer with CT− being the lowest and representing true CT-antibody-negative samples and CT+++ being the highest and representing exceptionally high levels of serum antibody.
Statistical methods
Finite mixture modeling assumes that each distribution G of titers y is a mixture of, say, D underlying latent dis-
, which we assume are normal on the log titer scale. We further assume that the only difference between cases (k = 1) and controls (k = 0) is in the proportions of samples from each of the latent component distri-
The proportion π kd is the proportion of samples that can be attributed to latent distribution d, conditional on case/control status k. 
with y on the natural log titer scale. Finally, the proportions of samples, α ki , in each titer category i in group k are obtained as the inner product of the θ di and the π kd :
The observed data are the number of samples r ki in each titer category i in TFI cases (k = 1) and controls (k = 0); this is multinomially distributed, with denominators n k :
This multinomial distribution is the appropriate choice for the observables, that is, n trials (samples) with k possible outcomes (titers) on each trial, and a fixed probability of each outcome over all of the trials. The secondary data source provides additional information on the proportion of true antibody-negative samples at each WIF titer (Table 1) . This was based on the Pgp3 assay, which we assume to be effectively 100% specific (33) . The data shown in Table 1 provide direct information on the probability ω ki of a sample's being in the CT− group, conditional on its titer and case/control status. This, in turn, constitutes indirect information on θ i 1 , the probability of a sample's having a specified titer, given that it is CT−. We can use Bayes' rule to relate the quantities, with the index "1" indicating the CT− distribution: Because we do not know the proportion of TFI cases in the secondary data set, we further define a weighted average of ω i 1 for cases and ω i 0 for controls, with the proportion who are cases p TFI to be estimated from the data:
The secondary data r i providing information on the ω i . represent the numbers of Pgp3-negatives in the sample n i with WIF titer i ( Table 1) . These have a binomial likelihood:
The secondary data cover only the first 6 titer categories, as there are no further Pgp3-negatives in higher WIF categories (Table 1) .
Estimation. We adopt a Bayesian approach and proceed with computations using the Markov chain Monte Carlo method, supplying weak or noninformative priors for μ d , π kd , and weakly informative priors for the standard deviation parameters σ d . Mixture models can be unstable, and technical details on priors and constraints adopted to achieve stability are supplied in Web Appendix 1 (available at http://aje.oxfordjournals.org/), along with WinBUGS code and data sets. Prior specifications are detailed in Web Appendix 2. We conducted a series of sensitivity analyses testing robustness to changes in priors and structural assumptions; these are described in Web Appendix 3. Deviance statistics (34) and comparison of observed and predicted counts of samples at each WIF titer were used to assess model fit and guide model selection. In a Bayesian Markov chain Monte Carlo framework, the residual deviance (35) is calculated on each iteration. The posterior mean residual deviance is a global measure of goodness of fit, and it is expected to be close to the number of observations if the model fits well. A reduction in residual deviance of 3-5 points is generally taken as evidence of a better-fitting model. Convergence was achieved within 10,000-15,000 iterations using Brooks and Gelman statistics (36) . Posterior results are based on a total 120,000 samples from 4 chains, after discarding the first 30,000 samples.
Estimates of PEF. In the "2-3" model, the distribution with the highest mean titer is found only in the TFI cases. Therefore, the proportion of TFI samples in the CT++ distribution in the "2-3" model is a direct estimate of the PEF: = π ++ PEF .
2-3 1,CT
In the "3-3" model, a more complicated situation arises:
Here an estimate of the PEF can be based on the excess proportion of samples in the highest CT++ category among TFI cases as compared with controls. Thus, it is necessary to take into account the fact that a proportion of the CT++ samples observed in the TFI cases would occur . This must be considered a lower bound estimate because it ignores the excess proportion of CT++ observed in TFI cases.
Acknowledging an excess of CT++ samples in TFI cases, in addition to the CT+++ samples, we can follow the same argument set out for the "3-3" model. This leads to a second estimate of the PEF for the "3-4" model, in which we add the proportion in CT+++ to the excess fraction of the CT++: This can be considered an upper bound estimate, as it ascribes all the excess numbers of CT++ samples among cases to a causal effect of CT infection. The equations for each estimate are presented in Table 2 . The extent to which these different estimates are vulnerable to confounding is considered in the Discussion. Table 3 compares the predicted titer distributions from each model with the observed data and shows the goodness of fit (residual deviance) at each point. Systematic error is evident in the "2-3" and "3-3" models, in that they underestimate the peak that can be seen in both control and TFI samples at 1:1,024, while overestimating the number of samples at 1:512. The "3-4" models, on the other hand, fit the distribution well at every point.
RESULTS
Model selection
The fit of models to data is elaborated further in Figures 1-4 . These plots depict the fitted component distributions for each model and separately for cases and controls, and they are drawn to the correct scale in order to reflect the fitted proportions of each component. The predicted overall titer distribution (solid black line) is the sum of the components and can be compared with the observed data, shown as a histogram.
In a good-fitting model the residual deviance should be no more than the number of data points, which is 8 each in the cases and controls. Therefore, the global residual deviance statistics presented in the bottom row of Table 3 rule out the "2-3" and "3-3" models decisively, with the "3-4" model having an excellent fit.
Parameter estimates and PEF
The estimated mean value and standard deviation for each of the log titer distributions, CT−, CT+, CT++, and CT+++, are shown in Table 4 , along with the proportions of cases and controls in each group. The introduction of a CT++ distribution for the controls in the "3-3" and "3-4" models has the effect of lowering the mean value of the CT+ distribution by about 1 log unit and lowering its variance somewhat. Similarly, the introduction of a CT+++ category lowers the mean of the CT++ group and also reduces its variance.
The secondary data source provides more information on the CT− distribution: The mean is raised to a somewhat higher titer, and the variance is reduced. Its main effect is to reduce uncertainty in the mean values and standard deviations of the CT− and CT+ distributions. The model fits the secondary data well, with a residual deviance of 4.0 on 6 observations, 2 of which are zeroes.
The central estimates of the PEF (Table 4) lie within the range 28%-48%. Although estimates from the "2-3" model can be discounted due its poor fit, it is interesting that it estimates almost exactly the same PEF as the upperbound estimate from the "3-4" model without secondary data. This shows that when the excess cases in the CT++ group are assumed to cause TFI, one obtains very similar results regardless of whether or not one distinguishes between the CT++ and CT+++ distributions. The secondary data have a slight impact on the estimates of PEF, lowering them by approximately 4 percentage points. As expected, the probability (Pr) that a sample in the secondary data set was from a TFI case and not a control was poorly estimated (Pr = 0.54, 95% credible interval (CrI): 0.04, 0.97), barely different from the prior.
We consider the estimates from the "3-4" model with secondary data to be the best available estimates from the study, due to their greater precision. The secondary data improve identification of the boundary between the CT− and CT+ distributions by eliminating the false positives in CT+. This can be observed by comparing the posterior means and 95% This has been plotted to cover the area −5 to +1 on the log titer scale; its area corresponds to the proportion of data at these titers. CT, Chlamydia trachomatis.
credible intervals of the means and standard deviations of the CT− and CT+ distributions (Table 4 ). Sensitivity analyses, described in Web Appendix 3 (Web Tables 1 and 2 ), showed that the main results were robust to reasonable changes in the priors, to distributional assumptions, and to the proportion of TFI cases in the secondary data.
DISCUSSION
Estimates of the proportion of PID, ectopic pregnancy, and infertility that can be attributed to Chlamydia are critical to the implementation of CT prevention and control programs. A number of authors have attempted to derive estimates of the PEF from serological case-control studies (13, 37), but these estimates were confounded by other exposures likely to occur in CT-exposed women that are also capable of causing reproductive damage (38) . Previously, Price et al. (39) attempted to derive estimates from a Dutch case-control study, taking into account the sensitivity and specificity of assays. That study was based on a form of the "2-3" mixture model but utilized reported summary data, which did not allow titer distributions to be modeled (40) . However, according to the report's authors, recruitment to the original study was likely to have been subject to selection biases (40) , and the resulting estimate of 45% (95% CrI: 28, 62) was likely to have been an overestimate. An estimate of 64% in Scotland was described as an upper bound (41) . All estimates of the PEF are, of course, specific to time and place. For public health purposes, estimates should be based on contemporary local data. This analysis has shown how serum antibody titer distributions from case-control studies can be used to generate estimates of the PEF, based on finite mixture analysis. By attributing the causal mechanisms for TFI to differences between cases and controls in specific components of the titer distributions rather than to differences in the overall prevalence of antibody, the mixture modeling approach reduces the extent to which PEF estimates are vulnerable to confounding-although it does not eliminate it, as discussed below.
The demonstration that there are 4 component distributions might appear surprising, rather than the 2-component seropositive and seronegative model that might have been expected. However, the source data used in this exercise (29) have features that were apparent in earlier literature. Histograms suggesting 2 seropositive "peaks" in control series have been published previously (11, 12, 16) . Similarly, the very high titers seen in women with reproductive damage have also been well-documented for PID/salpingitis (10, 18) and TFI (11, 15, 16, 30, 31) . Our analyses suggested that We attempted to fit "4-4" models but were unable to achieve stable results. Possibly, evidence for a "4-4" model might be obtained with a larger sample, although our efforts to fit these models suggested that very few controls would be in the CT+++ group. Interpretation of results for the different antibody-positive groups must be somewhat speculative. Given that salpingitis is a necessary condition for TFI (6, 32, 42) , it seems reasonable to regard the CT+++ group, which is observed in cases only, as representing a causal mechanism linked to CT-related TFI. It is tempting to attribute this to a greater inflammatory response that is possibly due to a higher infectious load in women who develop TFI, as has been observed for the lower genital tract and in PID (43, 44) . The 28.0% (95% CrI: 6.9, 50.0) estimate of PEF based on the CT+++ distribution alone can be regarded as a lower bound, because it ignores the excess CT++ observed in the cases.
This excess was substantial: 29.4% of TFI cases were in the CT++ group, compared with the 6.5% of the controls (Table 4 ). We may speculate that the CT++ peak in the women without TFI might represent women with previous upper genital tract infection in whom inflammation has resolved, either following treatment or spontaneously, without causing tubal damage (6, 45) , as well as women with recent lower genital tract infections or reinfections, since the decline in antibody levels over time is far less marked in second infections (46) . The excess CT++ seen in cases could simply be due to increased exposure to CT among women whose TFI was in fact caused by other sexually transmitted infections or bacterial vaginosis. Bacterial vaginosis is associated with TFI (47) and with increased likelihood of CT infection and PID (48, 49) . Sexual activity may also lead to ascending infection with common respiratory or enteric pathogens that colonize the genital tract, which are also capable of causing reproductive damage (50) .
Alternatively, women with TFI are more likely to have been exposed to repeat CT infections, which is associated with both reproductive damage (44, 51) and higher titers (46) . For this reason, we may regard the higher PEF estimate (43.0%, 95% CrI: 27.6, 57.5) as an upper bound, since it ascribes the entire excess CT++ in cases to a causal mechanism rather than being partly or wholly the result of positive confounding.
The advantage of the mixture model estimates compared with the standard formula for PEF from case-control studies (52) , is that they use the titer distribution as a marker of causal effect. This does not remove vulnerability to confounding, but it does limit it to a proportion of the CT++ distribution, subject of course to our interpretation of the distributions. We can contrast our estimates with those obtained from the standard formula for PEF from case-control studies. Using the same WIF data with titers at 1:64 and below as negatives, the odds ratio for TFI from Table 1 This was most likely an underestimate of π CT in the casecontrol study, because the mean age of women in the WIF data was 30 years. Applying the formula to these estimates gives a PEF of 65.4%, or 71.3% if π CT is 30%. Both of these estimates are upper bounds, as they attribute all of the excess prevalence to a causal effect; the lower bound is zero, representing the case in which CT has no causal role in TFI but exposure to CT is common among women exposed to the true causes.
Nevertheless, both higher and lower estimates generated by the mixture models should be viewed cautiously, for 2 reasons. First, the modeling process was not all preplanned: Each successive model was data-driven, motivated by a poor fit in the previous model. The formulae for the PEF estimates were also developed post hoc. Second, our findings were based on an analysis of data collected for a different purpose. Our results therefore need to be confirmed by a specifically planned study using modern assays, many of which are far more specific (33) . The method could also be extended by testing samples for evidence of other pathogens capable of causing reproductive damage, including Mycoplasma genitalium (54), bacterial vaginosis (47) , and possibly Neisseria gonorrhoeae (50) . The exercise could also be carried out on samples from women with PID and ectopic pregnancy. If our results can be confirmed, finite mixture modeling may offer a way of quantifying the role of Chlamydia in reproductive damage and form the basis for monitoring the impact of CT control programs in the population over time.
